LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Therapies targeting SRC family kinases (SFKs) have shown efficacy in treating non-small cell lung cancer (NSCLC). However, recent clinical trials have found that the SFK inhibitor dasatinib is ineffective in some patient cohorts. Regardless, dasatinib treatment may benefit some NSCLC patient subgrou...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Kim, Yu Jin, Hong, Sungyoul, Sung, Minjung, Park, Min Jeong, Jung, Kyungsoo, Noh, Ka-Won, Oh, Doo-Yi, Lee, Mi-Sook, Oh, Ensel, Shin, Young Kee, Choi, Yoon-La
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347739/
https://ncbi.nlm.nih.gov/pubmed/27756880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12657
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk